National Academies Press: OpenBook
« Previous: Appendix A: References
Suggested Citation:"Appendix B: Registered Attendees." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
×
Page 45
Suggested Citation:"Appendix B: Registered Attendees." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
×
Page 46
Suggested Citation:"Appendix B: Registered Attendees." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
×
Page 47
Suggested Citation:"Appendix B: Registered Attendees." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
×
Page 48

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

B Registered Attendees Neha Agarwal Lisheng Cai University of California–Berkeley National Institute of Mental Health Chiiko Asanuma Marc Cantillon National Institute of Mental Health Coalition Against Major Disease, Critical Path Helene Benveniste Juan Chavez University Medical Center at Stony Brook Regeneron Pharmaceuticals Lizbet Boroughs William Cho American Psychiatric Association Merck and Co., Inc. Linda Brady Alice Luo Clayton National Institute of Mental Health Journalist Health Vlad Coric Robbin Brodbeck Bristol-Myers Squibb Lundbeck Research USA Alan Cross Neil Buckholtz AstraZeneca Pharmaceuticals National Institute on Aging Jasbeer Dhawan Brookhaven National Laboratory 45

46 GLUTAMATE-RELATED BIOMARKERS IN DRUG DEVELOPMENT Dario Doller Frederick Knox Lundbeck Research USA United States Navy (Retired) Jamie Driscoll Jaya Kolli National Institute of Mental Ross University School of Medicine Health David Lee Melissa Dupree Foundation for NIH Fabiani & Company Serguei Liachenko Katherine Falk National Center for Toxicology Mt. Sinai School of Medicine Research Gwenaelee Fillon Johan Luthman Hoffman-La Roche, Inc. Merck and Co., Inc. Jarlath French-Mullen Ronald Marcus GeneLogic/Ocimum Biosolutions Bristol-Myers Squibb Robert Gibbons Michael Marino University of Illinois–Chicago Merck and Co., Inc. Sarah Grimwood Shawnmarie Mayrand-Ching Pfizer Inc. National Institutes of Health Michele Hindi-Alexander Diana Morales National Institutes of Health National Institutes of Health Garry Honey Laurie Nadler Pfizer Inc. National Institute of Mental Health Thomas Insel Richard Nakamura National Institute of Mental Health National Institute of Mental Health Carrie Jones Lindsay Pascal Vanderbilt University AAAS John Kehne Victor Pike Translational Neuropharmacology Consulting, LLC National Institute of Mental Health

47 APPENDIX B Jorge Quiroz Cristina Tan Hehir Hoffman-La Roche, Inc. GE Global Research Jean Rifkin Pam Tannenbaum Diabetes Seminars Merck and Co., Inc. Erica Rosemond Christian Thomsen National Institute of Mental Lundbeck Research USA Health Dan van Kammen Deborah Runkle CHDI Foundation AAAS Philip Wang Judy Siuciak National Institute of Mental Foundation at NIH Health Renuka Sriram Lois Winsky Pfizer Inc. National Institute of Mental Health Thomas Steckler Frank Yocca Johnson & Johnson AstraZeneca Pharmaceuticals Cyrille Sur Huailing Zhong Merck and Co., Inc. Lundbeck Research USA

Next: Appendix C: Agenda »
Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary Get This Book
×
Buy Paperback | $21.00 Buy Ebook | $16.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders. Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat.

Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders. Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!